Cunningham Andrea Lee
Known title: DirectorCIK: 0001903152
Associated companies
Transaction History
| TTD | ▲ Buy | Grant | 6,110 | $0 | 5/4/2026 | View on chart |
| TTD | ▲ Buy | Grant | 1,053 | $25K | 5/4/2026 | View on chart |
| TTD | ▲ Buy | Grant | 210 | $5K | 5/4/2026 | View on chart |
| TTD | ▲ Buy | Grant | 526 | $12K | 5/4/2026 | View on chart |
| TTD | ▲ Buy | Grant | 31 | $793 | 4/3/2026 | View on chart |
| TTD | ▲ Buy | Grant | 17 | $438 | 4/1/2026 | View on chart |
| TTD | ▼ Sell | Open Market | 1,403 | $68K | 9/10/2025 | View on chart |
| TTD | ▲ Buy | Grant | 2,450 | $0 | 5/27/2025 | View on chart |
| TTD | ▲ Buy | Grant | 422 | $25K | 5/27/2025 | View on chart |
| TTD | ▲ Buy | Grant | 50 | $3K | 5/27/2025 | View on chart |
| TTD | ▼ Sell | Open Market | 1,606 | $161K | 8/15/2024 | View on chart |
| TTD | ▲ Buy | Grant | 34 | $3K | 5/28/2024 | View on chart |
| TTD | ▲ Buy | Grant | 1,577 | $0 | 5/28/2024 | View on chart |
| TTD | ▲ Buy | Grant | 286 | $25K | 5/28/2024 | View on chart |
| TTD | ▼ Sell | Open Market | 2,504 | $215K | 9/13/2023 | View on chart |
| TTD | ▼ Sell | Open Market | 1,950 | $146K | 6/7/2023 | View on chart |
| TTD | ▲ Buy | Grant | 2,119 | $0 | 5/25/2023 | View on chart |
| TTD | ▲ Buy | Grant | 399 | $25K | 5/25/2023 | View on chart |
| TTD | ▲ Buy | Grant | 47 | $3K | 5/25/2023 | View on chart |
| TTD | ▲ Buy | Grant | 2,089 | $0 | 5/26/2022 | View on chart |
| TTD | ▲ Buy | Grant | 835 | $50K | 5/26/2022 | View on chart |
| TTD | ▲ Buy | Grant | 83 | $5K | 5/26/2022 | View on chart |
| TTD | ▲ Buy | Grant | 16 | $1K | 2/22/2022 | View on chart |
| TTD | ▲ Buy | Grant | 1,341 | $0 | 1/1/2022 | View on chart |
| TTD | ▲ Buy | Grant | 536 | $0 | 1/1/2022 | View on chart |
| TTD | ▲ Buy | Grant | 214 | $20K | 1/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
TTD down 77% while market rises; healthcare integration news
The Trade Desk shares have fallen 77% while the broader market has risen, leading to comparisons with other ad-tech stocks like Alphabet and AppLovin. Recent news highlights a healthcare inventory integration with OptimizeRx, which may be relevant to its advertising capabilities. Despite the significant price drop, the stock trades at a trailing P/E of 13.8, well below its 52-week high of $56.39.
TTD down 77% while market rises; healthcare integration news. The Trade Desk shares have fallen 77% while the broader market has risen, leading to comparisons with other ad-tech stocks like Alphabet and AppLovin. Recent news highlights a healthcare inventory integration with OptimizeRx, which may be relevant to its advertising capabilities. Despite the significant price drop, the stock trades at a trailing P/E of 13.8, well below its 52-week high of $56.39.